← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 19, 2017Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2010
Cantargia AB— Founded
Drugs by trial phase (13 distinct, 8 trials)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07281716CollaboratorPhase 1/Phase 2Dec 31, 2025
- NCT07284485CollaboratorPhase 2Dec 15, 2025
- NCT06143371Lead sponsorPhase 1Aug 21, 2023
- NCT05181462Lead sponsorPhase 1/Phase 2Jan 11, 2022
- NCT05181462Study directorPhase 1/Phase 2Jan 11, 2022
- NCT05181462OfficialPhase 1/Phase 2Jan 11, 2022
- NCT05116891Study directorPhase 1/Phase 2Sep 22, 2021
- NCT05116891Lead sponsorPhase 1/Phase 2Sep 22, 2021
- NCT04990037Study directorPhase 1Jul 31, 2021
- NCT04990037Lead sponsorPhase 1Jul 31, 2021
- NCT04452214Study directorPhase 1Sep 24, 2020
- NCT04452214Lead sponsorPhase 1Sep 24, 2020
- NCT03267316Lead sponsorPhase 1/Phase 2Sep 19, 2017
Details
- Founded
- Lund, SE Jun 1, 2010
- Last known activity
- Dec 31, 2025